These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 22957648)

  • 21. High prevalence of androgen deficiency and abnormal lipid profile in infertile men with non-obstructive azoospermia.
    Bobjer J; Naumovska M; Giwercman YL; Giwercman A
    Int J Androl; 2012 Oct; 35(5):688-94. PubMed ID: 22519695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feedback inhibition of gonadotropins by testosterone in men with hypogonadotropic hypogonadism: comparison to the intact pituitary-testicular axis in primary hypogonadism.
    Shimon I; Lubina A; Gorfine M; Ilany J
    J Androl; 2006; 27(3):358-64. PubMed ID: 16474013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido).
    Moisey R; Swinburne J; Orme S
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):642-7. PubMed ID: 18394021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells.
    Brenk M; Scheler M; Koch S; Neumann J; Takikawa O; Häcker G; Bieber T; von Bubnoff D
    J Immunol; 2009 Jul; 183(1):145-54. PubMed ID: 19535644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypogonadism in male outpatients with sarcoidosis.
    Spruit MA; Thomeer MJ; Gosselink R; Wuyts WA; Van Herck E; Bouillon R; Demedts MG; Decramer M
    Respir Med; 2007 Dec; 101(12):2502-10. PubMed ID: 17855065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy.
    Lanfranco F; Zitzmann M; Simoni M; Nieschlag E
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):500-7. PubMed ID: 15049966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reserved Sertoli cell function in the hypogonadic male patients with myotonic dystrophy.
    Lou XY; Nishi Y; Haji M; Antoku Y; Tanaka S; Ikuyama S; Yanase T; Takayanagi R; Nawata H
    Fukuoka Igaku Zasshi; 1994 May; 85(5):168-74. PubMed ID: 8020867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Periodontal status in men with hypergonadotropic hypogonadism: effects of testosterone deficiency.
    Daltaban O; Saygun I; Bolu E
    J Periodontol; 2006 Jul; 77(7):1179-83. PubMed ID: 16805680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte subset distribution and natural killer cell activity in men with idiopathic hypogonadotropic hypogonadism.
    Kiess W; Liu LL; Hall NR
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):399-404. PubMed ID: 2031438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of serum IGF-I and testosterone on lipid and glycemic profile in acromegalic men].
    Figueiredo PR; Martins MR; Montenegro RM; Albano MF; Montenegro RM
    Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):1026-32. PubMed ID: 20126857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypogonadism in aged hospitalized male patients: prevalence and clinical outcome.
    Iglesias P; Prado F; Macías MC; Guerrero MT; Muñoz A; Ridruejo E; Tajada P; García-Arévalo C; Díez JJ
    J Endocrinol Invest; 2014 Feb; 37(2):135-41. PubMed ID: 24497212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age Induced Nitroso-Redox Imbalance Leads to Subclinical Hypogonadism in Male Mice.
    Lee JA; Kuchakulla M; Arora H; Kulandavelu S; Gonzalez E; Masterson TA; Hare JM; Kaiser UB; Ramasamy R
    Front Endocrinol (Lausanne); 2019; 10():190. PubMed ID: 30984111
    [No Abstract]   [Full Text] [Related]  

  • 33. [When is determination of serum testosterone levels in men indicated?].
    Köhn FM; Schuppe HC
    MMW Fortschr Med; 2017 Jun; 159(10):42-46. PubMed ID: 28550547
    [No Abstract]   [Full Text] [Related]  

  • 34. Re: circulating endothelial cells as marker of endothelial damage in male hypogonadism.
    Seftel AD
    J Urol; 2013 Feb; 189(2):652-3. PubMed ID: 23312191
    [No Abstract]   [Full Text] [Related]  

  • 35. Testosterone replacement therapy in hypogonadal men is associated with increased expression of LAMP-2 (CD107b) by circulating monocytes and dendritic cells.
    Corrales JJ; Almeida M; Martín-Martín L; Miralles JM; Orfao A
    Clin Endocrinol (Oxf); 2014 Apr; 80(4):577-84. PubMed ID: 24111582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen and Androgen Receptors as Regulators of Monocyte and Macrophage Biology in the Healthy and Diseased Lung.
    Becerra-Diaz M; Song M; Heller N
    Front Immunol; 2020; 11():1698. PubMed ID: 32849595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hallmarks of sex bias in immuno-oncology: mechanisms and therapeutic implications.
    Xiao T; Lee J; Gauntner TD; Velegraki M; Lathia JD; Li Z
    Nat Rev Cancer; 2024 May; 24(5):338-355. PubMed ID: 38589557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RISING STARS: Androgens and immune cell function.
    Ainslie RJ; Simitsidellis I; Kirkwood PM; Gibson DA
    J Endocrinol; 2024 Jun; 261(3):. PubMed ID: 38579776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA modification regulator DDC in endometrial cancer affects the tumor microenvironment and patient prognosis.
    Zhao H; Shi C; Zhao G; Liu J; Wang X; Liang J; Li F
    Sci Rep; 2023 Oct; 13(1):18057. PubMed ID: 37872211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extra-Gonadal and Non-Canonical Effects of FSH in Males.
    Spaziani M; Carlomagno F; Tenuta M; Sesti F; Angelini F; Bonaventura I; Ferrari D; Tarantino C; Fiore M; Petrella C; Tarani L; Gianfrilli D; Pozza C
    Pharmaceuticals (Basel); 2023 May; 16(6):. PubMed ID: 37375761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.